Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF Mags

Total Page:16

File Type:pdf, Size:1020Kb

Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF Mags A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS Revolutionize life The Axiom Genotyping Solution — Conquer the next wave of genomic discoveries. Our next-generation genotyping technology allows you to leverage high-value markers from our proprietary data set, public databases, and your scientific collaborations to find new genetic associations. The Axiom™ Genotyping Solution includes array plates with unique genomic content, complete reagent kits, analysis software, and the new GeneTitan™ Instrument for hands-free sample processing. Trust the Axiom Genotyping Solution to provide: Flexible content – optimize your studies with a diverse set of relevant and novel variants Fast results – process more than 750 samples/week—the highest throughput in the industry More power – run more samples within your budget Greater confidence – generate reliable results with end-to-end automated sample processing Conquer the next wave of genomic discoveries: Visit booth #415 or www.axiom.affymetrix.com And attend our seminar: New Microarray Solutions for GWAS and Cytogenetics Wed., Oct. 21, 11:30 A.M.–1:00 P.M., Room 314, Convention Center A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS Contents | Zoom in | Zoom out For navigation instructions please click here Search Issue | Next Page BONUS: TRADITIONAL & DIGITAL GENE EXPRESSION OCTOBER 2009 GEORGE WEINSTOCK, WASHINGTON UNIVERSITY IN ST. LOUIS The Human Microbiome Companion Diagnostics I Gene Expression in the Brain Contents | Zoom in | Zoom out For navigation instructions please click here Search Issue | Next Page A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS New...NimbleGen Human CGH/CNV 3x720K Arrays Catch Copy Number Variants Genome-Wide NimbleGen Human CGH 3x720K Whole-Genome v3.0 Array 35 kb Comprehensively detect CNVs with 720,000 probes per sample and enhanced coverage of low-copy repeat regions of 382 kb Competitor’s 244K array the genome (e.g. segmental duplications). “Normal” CNVs Increase Throughput, Decrease Costs NimbleGen 3x720K arrays enable simultaneous analysis of Segmental Duplications 3 samples on a single slide, providing increased throughput and cost-effective analysis. Known Genes Discover the NimbleGen Difference Analysis of a Complex CNV Region in Chromosome 17 in a Burkitt The proof is in our data. See how NimbleGen Lymphoma Research Sample Referenced against Normal Genomic DNA. An ~382 kb deletion region and an ~35 kb amplification region are Human CGH/CNV 3x720K Arrays easily detected using the NimbleGen Human CGH 3x720K Whole-Genome Tiling v3.0 array and the NimbleGen MS 200 Microarray Scanner at 2 μm compare to your current technology. resolution. The combination of high-density NimbleGen microarrays and the high-resolution scanning of the MS 200 provides sensitivity to comprehensively detect genome-wide CNVs. Catch what you’ve been missing: www.nimblegen.com/cgh3x720k Roche NimbleGen, Inc. Madison, WI USA For life science research only. Not for use in diagnostic procedures. NIMBLEGEN is a trademark of Roche. © 2009 Roche NimbleGen, Inc. All rights reserved. A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS OCTOBER 2009 Contents “We just don’t know that much about our relationship between our human cells and our microbial cells.” Julia Segre, Page 42 Gene PGx Sequencing Expression Companion Humans as Host Diagnostics Take Off Participants are calling the New Tools in Pharma is realizing that it Human Microbiome Project Neuroscience needs to collaborate with a second Human Genome A brain atlas was once on the diagnostic companies to Project. The massive global order of a coffee table book, stratify patients and to make effort aims to get to the known for its large, glossy safer, more effective drugs. bottom of the relationship illustrations. Today’s brain But obstacles remain in the between microorganism and atlases — led largely by the path to full flight. host, and disease and health. Allen Institute for Brain Sci- BY JEANENE SWANSON BY CIARA CURTIN ence — capitalize on localized gene expression and other data to truly revolutionize the field of neuroscience. BY MEREDITH W. SALISBURY 33 38 30 On The Cover 38 The Human Microbiome 33 Companion Diagnostics 30 Gene Expression in the Brain PHOTOGRAPH BY BOB BOSTON FOR GENOME TECHNOLOGY OCTOBER 2009 GENOME TECHNOLOGY 3 A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS _____________________ A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS OCTOBER 2009 Contents 10 20 53 Markers In every issue Upstream NIH .......................................................10 PRIMER .................................................7 PROTEOMICS ................................... 45 Collins steps into new directorship We all have our bugs Grant supports proteomics with goals at the ready; funding synchrotron work stability a priority WHERE ARE THEY NOW? .................9 Kathy Hudson, next-gen SEQUENCING....................................47 NANOMEDICINE................................11 sequencing on the rise, Centers of Complete Genomics raises Jamey Marth to direct new nano Excellence in Genomic Sciences, $45 million in Series D center at UC-Santa Barbara, and more Burnham RNAI.................................................... 49 ZEITGEIST...........................................16 UMass, Whitehead fire new salvo in SEQUENCING.................................... 12 A blog around the world Tuschl IP suit UW group sequences exomes from 12 people, confirms gene for rare CAREERS............................................19 MICROARRAYS................................. 50 disease The journal perspective Affy inks deal with Beckman for custom tools SYNTHETIC GENOMICS. ................ 13 LAB REUNION .................................. 20 Venter Institute team demonstrates ‘A community of scholars’ BIOINFORMATICS ............................ 51 successful cross-species genome Pharma calls for a pre-competitive UNDER ONE ROOF. ......................... 22 approach METHYLATION.................................. 14 A grassroots institute Markowitz, Vogelstein lead development of novel detection MYTAKE............................................. 25 Downstream technique Project annotation PGX ..................................................... 52 STRUCTURAL VARIATION.............. 14 BRUTE FORCE...................................27 Celera hones panel for non-small New BreakDancer algorithm Personal supercomputers? cell lung cancer performs high-res mapping of Q&A..................................................... 53 indels, more UPCOMING EVENTS....................... 56 Innovation through imaging BLUNT END....................................... 58 PCR ...................................................... 15 CASE STUDY..................................... 55 CDC evaluates rapid flu tests versus The peptide blockade rRT-PCR for detecting novel strain of H1N1 influenza OCTOBER 2009 GENOME TECHNOLOGY 5 A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS ___________________ _____________ A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS A Genome Technology Previous Page | Contents | Zoom in | Zoom out | Front Cover | Search Issue | Next Page BEF MaGS FROM THE EDITOR Primer ISSUE NO. 95 125 Maiden Lane, Second Floor New York, NY 10038 We All Have Our Bugs Tel +1 212 269 4747 Fax +1 212 269 3686 ____________GENOMEWEB.COM t was several years ago that I first heard about a major study of EDITORIAL DIRECTOR the human microbiome — it was from Washington University’s Meredith W. Salisbury [email protected]_______________ Jeff Gordon, presenting at a Marco Island conference some of SENIOR EDITOR the earliest genomics-based research into the microbial content Ciara Curtin [email protected]_____________ SENIOR WRITERS of our bodies. At the time, many attendees were surprised to Matthew Dublin [email protected] Ihear that microbial cells outnumber human cells 10 to one in the Jeanene Swanson [email protected]______________ ART DIRECTOR average human. Rarely have so many scientists been sent scrambling Therese Shechter [email protected]_______________ for hand sanitizer — but, it seems, they also scrambled to participate GENOMEWEB DAILY NEWS in the nascent microbiome field. Ed Winnick, Editorial Director [email protected]______________ By 2007, NHGRI launched its large-scale Human Microbiome Matt Jones,
Recommended publications
  • Informa Tics for Genome Analysis, Biomarkers,And Ta Rget Disco Very
    Register by March 14 and Save up to $200! Final Agenda Cambridge Healthtech Institute’s Sixth Annual April 28 – 30, 2008 • World Trade Center • Boston, MA Keynote Presentations by: Concurrent Tracks: • Informatics and IT Infrastructure & Operations • Informatics for Genome Analysis, Biomarkers, and Target Discovery Linda Avey co-Founder • Predictive and in silico Science 23andMe, Inc. • eChemistry Solutions • Clinical and Medical Informatics Joshua Boger, Ph.D. President & Chief Executive Offi cer Keynote Panel: A Must-Attend Event for the Life Vertex Pharmaceuticals, Inc. The Future of Personal Genomics: A special plenary panel discussion featuring George Church,Science Ph.D., Harvard IT Medical& Informatics School Community Dietrich Stephan, Ph.D., Navigenics John Reynders, Ph.D. Jeffrey M. Drazen, M.D., New England Journal of Medicine/Harvard Vice President & Chief Information Offi cer Medical School Johnson & Johnson, Pharma R&D Fred D. Ledley, M.D., Bentley College ...and more 2008 Benjamin Franklin Award EEventvent FFeatures:eatures: presented by Bioinformatics.org • Access All Five Tracks for One Price • Network with 1,500+ Delegates Platinum Sponsors: • Hear 85+ Technology and Scientifi c Presentations • Choose from Four Pre-conference Workshops, the Oracle Life Sciences and Healthcare User Group Meeting, and Symyx Software Symposium 2008 Gold Sponsors: • Attend Bio-IT World’s Best Practices Awards NEW Bronze Sponsor: • Connect with Attendees Using CHI’s Intro-Net Corporate Support: • Participate in the Poster Competition • See the Winners of the following 2008 Awards: Offi cial Publication: Benjamin Franklin Best of Show Lead Sponsoring Publications: Best Practices • View Who’s Who & What’s New in the Exhibit Hall • And Much More! www.Bio-ITWorldExpo.com Organized & Managed by: Cambridge Healthtech Institute 250 First Avenue, Suite 300, Needham, MA 02494 • Phone: 781-972-5400 • Fax: 781-972-5425 • Toll-free in the U.S.
    [Show full text]
  • Research Laboratory of Electronics
    Research Laboratory of Electronics The Research Laboratory of Electronics (RLE) at MIT is a vibrant intellectual community and was one of the Institute’s earliest modern interdepartmental academic research centers. RLE research encompasses both basic and applied science and engineering in an extensive range of natural and man-made phenomena. Integral to RLE’s efforts is the furthering of scientific understanding and leading innovation to provide great service to society. The lab’s research spans the fundamentals of quantum physics and information theory to synthetic biology and power electronics and extends to novel engineering applications, including those that produce significant advances in communication systems or enable remote sensing from aircraft and spacecraft, and the development of new biomaterials and innovations in diagnostics and treatment of human diseases. RLE was founded in 1946 following the groundbreaking research that led to the development of ultra-high-frequency radar, a technology that changed the course of World War II. It was home to some of the great discoveries made in the 20th century at MIT. Cognizant of its rich history and focus on maintaining its position as MIT’s leading interdisciplinary research organization, RLE fosters a stimulating and supportive environment for innovative research and impact. What distinguishes RLE today from all other entities at MIT is its breadth of intellectual pursuit and diversity of research themes. The lab supports its researchers by providing a wide array of services spanning financial and human resources (HR), information technology, and renovations. It is fiscally independent and maintains a high level of loyalty from its principal investigators (PIs) and staff.
    [Show full text]
  • View Publication
    Downloaded from rsif.royalsocietypublishing.org on 20 April 2009 Towards programming languages for genetic engineering of living cells Michael Pedersen and Andrew Phillips J. R. Soc. Interface published online 15 April 2009 doi: 10.1098/rsif.2008.0516.focus Supplementary data "Data Supplement" http://rsif.royalsocietypublishing.org/content/suppl/2009/04/15/rsif.2008.0516.focus.D C1.html References This article cites 19 articles, 7 of which can be accessed free http://rsif.royalsocietypublishing.org/content/early/2009/04/14/rsif.2008.0516.focus.full. html#ref-list-1 P<P Published online 15 April 2009 in advance of the print journal. Subject collections Articles on similar topics can be found in the following collections synthetic biology (9 articles) Email alerting service Receive free email alerts when new articles cite this article - sign up in the box at the top right-hand corner of the article or click here Advance online articles have been peer reviewed and accepted for publication but have not yet appeared in the paper journal (edited, typeset versions may be posted when available prior to final publication). Advance online articles are citable and establish publication priority; they are indexed by PubMed from initial publication. Citations to Advance online articles must include the digital object identifier (DOIs) and date of initial publication. To subscribe to J. R. Soc. Interface go to: http://rsif.royalsocietypublishing.org/subscriptions This journal is © 2009 The Royal Society Downloaded from rsif.royalsocietypublishing.org on 20 April 2009 J. R. Soc. Interface doi:10.1098/rsif.2008.0516.focus Published online Towards programming languages for genetic engineering of living cells Michael Pedersen1,2 and Andrew Phillips1,* 1Microsoft Research Cambridge, Cambridge CB3 0FB, UK 2LFCS, School of Informatics, University of Edinburgh, Edinburgh EH8 9AB, UK Synthetic biology aims at producing novel biological systems to carry out some desired and well-defined functions.
    [Show full text]
  • SYNTHETIC BIOLOGY and ITS POTENTIAL IMPLICATIONS for BIOTRADE and ACCESS and BENEFIT-SHARING ©2019, United Nations Conference on Trade and Development
    UNITED NATIONS CONFERENCE ON TRADE AND DEVELOPMENT SYNTHETIC BIOLOGY AND ITS POTENTIAL IMPLICATIONS FOR BIOTRADE AND ACCESS AND BENEFIT-SHARING ©2019, United Nations Conference on Trade and Development. All rights reserved. The trends, figures and views expressed in this publication are those of UNCTAD and do not necessarily represent the views of its member States. The designations employed and the presentation of material on any map in this work do not imply the expression of any opinion whatsoever on the part of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. This study can be freely cited provided appropriate acknowledgment is given to UNCTAD. For further information on UNCTAD’s BioTrade Initiative please consult the following website: http://www.unctad. org/biotrade or contact us at: [email protected] This publication has not been formally edited. UNCTAD/DITC/TED/INF/2019/12 AND ITS POTENTIAL IMPLICATIONS FOR BIOTRADE AND ACCESS AND BENEFIT-SHARING iii Contents Acknowledgements ................................................................................................................................iv Abbreviations ...........................................................................................................................................v EXECUTIVE SUMMARY ............................................................................................. vi SECTION 1: INTRODUCTION TO BIOTRADE,
    [Show full text]
  • Realizing the Potential of Synthetic Biology
    Nature Reviews Molecular Cell Biology | AOP, published online 12 March 2014; doi:10.1038/nrm3767 PERSPECTIVES computer-aided-design (CAD), safety sys- VIEWPOINT tems, integrating models, genome editing and accelerated evolution. Synthetic biology Realizing the potential of synthetic is less like highly modular (or ‘switch-like’) electrical engineering and computer science biology and more like civil and mechanical engineer- ing in its use of optimization of modelling of whole system-level stresses and traffic flow. George M. Church, Michael B. Elowitz, Christina D. Smolke, Christopher A. Voigt and Ron Weiss Michael B. Elowitz. At the most general level, synthetic biology expands the subject Abstract | Synthetic biology, despite still being in its infancy, is increasingly matter of biology from the (already enor- providing valuable information for applications in the clinic, the biotechnology mous) space of existing species and cellular industry and in basic molecular research. Both its unique potential and the systems that have evolved to the even larger challenges it presents have brought together the expertise of an eclectic group of space of non-natural, but feasible, species scientists, from cell biologists to engineers. In this Viewpoint article, five experts and systems. Although we started with circuits to carry out the simplest kinds of discuss their views on the future of synthetic biology, on its main achievements in dynamic behaviours, synthetic approaches basic and applied science, and on the bioethical issues that are associated with the can be applied broadly to all types of bio­ design of new biological systems. logical functions from metabolism to multi­ cellular development. Synthetic biology allows us to figure out what types of genetic An increasing number of publications For instance, insight gained from systems circuit designs are capable of implement- and institutions are dedicated to biology investigations of natural processes ing different cellular behaviours, and what synthetic biology.
    [Show full text]
  • 2018 Semiconductor Synthetic Biology Roadmap
    2018 Semiconductor Synthetic Biology Roadmap Editor’s Note Victor Zhirnov Chief Scientist at Semiconductor I am delighted to introduce the 1st Edition of the SemiSynBio Roadmap, a collective Research Corporation and Editor of work by many dedicated contributors from industry, academia and government. the 1st Edition of the Semiconductor It can be argued that innovation explosions often occur at the intersection of Roadmap. scientific disciplines, and Semiconductor Synthetic Biology or SemiSynBio is an excellent example of this. The objective of this Roadmap is to serve as a vehicle to realize the transformative potential of the new technology emerging at the interface between semiconductors and synthetic biology. The SemiSynBio Roadmap is intended to catalyze both interest in and rapid technological advances that provide new capabilities that benefit humankind. Victor Zhirnov is Chief Scientist at the Semiconductor Research Corporation. His research interests include nanoelectronics devices and systems, properties of materials at the nanoscale, bio-inspired electronic systems etc. He has authored and co-authored over 100 technical papers and contributions to books. Victor Zhirnov served as the Chair of the Emerging Research Device (ERD) Working Group for the International Technology Roadmap for Semiconductors (ITRS). Victor Zhirnov also holds adjunct faculty position at North Carolina State University and has served as an advisor to a number of government, industrial, and academic institutions. Victor Zhirnov received the M.S. in applied physics from the Ural Polytechnic Institute, Ekaterinburg, Russia, and the Ph.D. in solid state electronics and microelectronics from the Institute of Physics and Technology, Moscow, in 1989 and 1992, respectively. From 1992 to 1998 he was a senior scientist at the Institute of Crystallography of Russian Academy of Science in Moscow.
    [Show full text]
  • Genocad Introduction
    GenoCAD Introduction Computer-Assisted Design Software for Synthetic Biology Materials prepared by: Mary E. Mangan PhD www.openhelix.com/genocad Version 1 GenoCAD Introduction Agenda Introduction to GenoCAD genocad.org Introduction and Credits Register and Log In Step 1: Parts Parts Grammar Import the Training Set Step 2: Design Step 3: Simulate Summary Exercises GenoCAD: http://www.genocad.org/ Computer-assisted design software for synthetic biology Visit GenoCAD.org 1 Support for GenoCAD Process Flow click peccoud.org nsf.gov Parts and grammars, public or custom collections Peccoud team Design constructs NSF support Simulate processes Conceptual Framework for GenoCAD Data Model, Concepts Promoters Coding Seqs Terminators peccoud.vbi.vt.edu/publications 2007: 10.1093/bioinformatics/btm446 2009: 10.1371/journal.pcbi.1000529 Promoter A Coding Seq A Promoter B Coding Seq B Your constructs Parts form the foundation, stored in project libraries Aspects of DNA function explained with language metaphors: transcription, translation, code Grammar rules specify the way the parts work in series GenoCAD lets you develop language for programming cells Parts + Grammars give you synthetic construct designs 2 Further Reading Getting Assistance doi: 10.1093/bioinformatics/btm446 doi: 10.1371/journal.pcbi.1000529 doi: 10.1093/nar/gkp361 doi: 10.1016/j.tibtech.2011.09.001 support Help: context-sensitive help from ? Button Publications: theoretical, software, ongoing development Support link for asking questions or offering feedback
    [Show full text]
  • Computational Tools and Algorithms for Designing Customized
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE REVIEW ARTICLE published: 06provided October by 2014 Frontiers - Publisher Connector BIOENGINEERING AND BIOTECHNOLOGY doi: 10.3389/fbioe.2014.00041 Computational tools and algorithms for designing customized synthetic genes Nathan Gould 1, Oliver Hendy 2 and Dimitris Papamichail 1* 1 Department of Computer Science, The College of New Jersey, Ewing, NJ, USA 2 Department of Biology, The College of New Jersey, Ewing, NJ, USA Edited by: Advances in DNA synthesis have enabled the construction of artificial genes, gene cir- Ilias Tagkopoulos, University of cuits, and genomes of bacterial scale. Freedom in de novo design of synthetic constructs California, Davis, USA provides significant power in studying the impact of mutations in sequence features, and Reviewed by: verifying hypotheses on the functional information that is encoded in nucleic and amino Yinjie Tang, Washington University, USA acids. To aid this goal, a large number of software tools of variable sophistication have M. Kalim Akhtar, University College been implemented, enabling the design of synthetic genes for sequence optimization London, UK based on rationally defined properties. The first generation of tools dealt predominantly *Correspondence: with singular objectives such as codon usage optimization and unique restriction site incor- Dimitris Papamichail, Department of Computer Science, The College of poration. Recent years have seen the emergence of sequence design tools that aim to New Jersey, 2000 Pennington Road, evolve sequences toward combinations of objectives.The design of optimal protein-coding Ewing, NJ 08628, USA sequences adhering to multiple objectives is computationally hard, and most tools rely on e-mail: [email protected] heuristics to sample the vast sequence design space.
    [Show full text]
  • Bioinformatics in Metabolic Engineering
    International Journal of Research Studies in Biosciences (IJRSB) Volume 7, Issue 11, 2019, PP 10-13 ISSN No. (Online) 2349-0365 DOI: http://dx.doi.org/10.20431/2349-0365.0711002 www.arcjournals.org Bioinformatics in Metabolic Engineering Nida Tabassum Khan*, Namra Jameel, Muhammad Jibran Khan Department of Biotechnology, Faculty of Life Sciences and Informatics, Balochistan University of Information Technology Engineering and Management Sciences, (BUITEMS), Quetta, Pakistan *Corresponding Author: Nida Tabassum Khan, Department of Biotechnology, Faculty of Life Sciences and Informatics, Balochistan University of Information Technology Engineering and Management Sciences, (BUITEMS), Quetta, Pakistan. Abstract: The emergence of metabolic engineering is strengthened by the tools of bioinformatics that not only supports experimental techniques employed for the manipulation of biological pathways but also provides an insilco platform for their study. There are numerous bioinformatics tools and software such as KEGG, MetaCyc,PH USER, Cytoscape etc that could be utilized by researchers in effectively transforming cellular pathways. Keywords: Systems biology ontology; Metabolic pathways; Gene network; Network visualization 1. INTRODUCTION Metabolic engineering integrates efficient exploration of metabolic and cellular pathways with molecular systems to enhance biological properties by formulating and applying genetic alterations [1].Decades ago, computational tools were used in metabolic engineering to design single enzymes by using analog computers, and digital computers were used to design the dynamics of metabolic pathways [2]. In recent years, bioinformatics tools are used to search huge metabolic databases leading to better understanding, managing, analyzing and visualizing of metabolic pathways [3, 4]. 2. APPLICATIONS OF BIOINFORMATICS TOOLS IN METABOLIC ENGINEERING There are several applications of bioinformatics tools in metabolic engineering which are as follows: 2.1.
    [Show full text]
  • BRIAN W. BRAMLETT [email protected] | 503.757.8626
    BRIAN W. BRAMLETT [email protected] | 503.757.8626 uniquely experienced technology strategist | trans-disciplinary leader | collaborative instigator Driven by an omnivorous curiosity and equipped with a robust foundation in applied physics, electrical engineering, and computer science, my career has been rooted in exploring the design and development of useful systems challenging conventional limits of scale & complexity. The experiences of over two decades of collaborations with highly skilled colleagues from diverse professional backgrounds has provided unparalleled opportunities to learn from and integrate perspectives across many disciplines. Along with the pragmatic focus of these unique expeditions, the process cultivated the deep exposure necessary to develop effective practices, organizational structures, communication techniques, and leadership skills in inter-disciplinary teams and cultures. From this background, I established a strong history of defining technically-grounded business strategies coupled with crafting a coherent, shared vision to motivate and guide successful delivery. HIGHLIGHTS Technology Strategy Developed corporate-wide frameworks and methods for evaluating technology opportunities in conjunction with business goals and user-centered design research. Piloted and refined structured innovation programs to discover and explore new markets and business models through rapid prototyping and direct engagement of customers. Product Design & Development Led agile, interdisciplinary teams combining expertise and techniques of ethnography, industrial, and interaction design with world-leading technologists in board, silicon, mechanical/thermal, and software engineering to create award-winning, real-world products across a broad range of markets. Deep expertise in evaluating approaches to highly complex and technically challenging engineering problems, particularly in the unique patterns that emerge when combining the extremes of very small parts integrated into large coordinated systems.
    [Show full text]
  • Moclo Planner: Interactive Visualization for Modular Cloning Bio-Design
    DRAFT MoClo Planner: Interactive Visualization for Modular Cloning Bio-Design Orit Shaer1, Consuelo Valdes1, Sirui Liu1, Kara Lu1, Traci L. Haddock2, Swapnil Bhatia2, Douglas Densmore2, Robert Kincaid3 1Wellesley College, 2Department of Electrical and Computer Engineering Boston University, 3Agilent Technologies The field applies engineering principles such as abstraction ABSTRACT and modularity into biological research, while solving problems MoClo Planner is an interactive visualization system for by applying a forward engineering approach: composing a collaborative bio-design, utilizing a multi-touch interactive specification of the behavior to be designed into an organism, and surface. The system integrates the information gathering, design, then selecting genetic parts and their regulatory architecture to and specification of complex synthetic biological constructs using achieve the functional goal. Here, genetic elements are treated as the Modular Cloning (MoClo) assembly method. Modular standardized biological parts, and used like “Legos” based on data Cloning is a hierarchical DNA construction method that allows about their behavior in a simpler context. An implication of this for the assembly of multi-part constructs from a library of approach is that synthetic biologists must engineer complex biological parts in a one-pot reaction. This cutting-edge method systems based on uncertain biological mechanisms. facilitates and expedites the assembly of complex biological The bottlenecks and challenges along the path to realizing designs. However, it is an intricate multi-step process, which to the full potential of this field are formidable and numerous. For date, has not been adequately supported by existing bio-design one, synthetic biology design requires large design spaces to be tools. Novel visual tools are needed in order to make MoClo more sampled combinatorially while applying voluminous experimental tractable and accessible to a broad range of users, to facilitate a design for each design candidate.
    [Show full text]
  • Genocad for Igem: a Grammatical Approach to the Design of Standard-Compliant Constructs Yizhi Cai, Mandy L
    Published online 18 February 2010 Nucleic Acids Research, 2010, Vol. 38, No. 8 2637–2644 doi:10.1093/nar/gkq086 GenoCAD for iGEM: a grammatical approach to the design of standard-compliant constructs Yizhi Cai, Mandy L. Wilson and Jean Peccoud* Virginia Bioinformatics Institute, Virginia Polytechnic Institute and State University, Washington St MC 0477, Blacksburg VA 24061, USA Received December 13, 2009; Revised January 28, 2010; Accepted February 1, 2010 ABSTRACT can be ligated without recreating any of the prefix and suffix restriction sites. The legacy sequence between two One of the foundations of synthetic biology is the adjoining parts is called the scar. BioBrick parts are phys- project to develop libraries of standardized genetic ically composable in the sense that the assembly of two parts that could be assembled quickly and cheaply BioBricks results in a new part compliant with the same into large systems. The limitations of the initial standard. The first BioBrick assembly standard, BBa1.0, BioBrick standard have prompted the development was proposed by Knight in a BBF Request For Comments of multiple new standards proposing different (BBF RFC 10). It uses EcoRI, NotI and Xbal in the avenues to overcome these shortcomings. The prefix, and SpeI, NotI and PstI in the suffix. Later on, it lack of compatibility between standards, the com- has been proposed to replace PstI with SbfI, an enzyme pliance of parts with only some of the standards or with a longer restriction site less likely to be found in parts even the type of constructs that each standard sequences (BBF RFC 11).
    [Show full text]